President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money. United States Politics and Government, GLP-1 RAs (Drug), Prices (Fares, Fees and Rates), Weight, Obesity, Medicaid, Medicare, Health Insurance and Managed Care, Regulation and Deregulation of Industry, Customs (Tariff), Eli Lilly and Company, Novo Nordisk A/S, Trump, Donald J, Biden, Joseph R Jr, Wegovy, Zepbound Read More
Trump Announces Deal to Drop Obesity Drug Prices to as Little as $149 a Month
